Author: Brandon Neary
President, OraPath
Modern molecular diagnostics have made the underlying data remarkably reproducible — a saliva sample analyzed by qPCR returns the same organisms at the same concentrations no matter which office collected it. But that reproducibility ends at the report. Hand the same result to five clinicians and you can get five interpretations, and the variation an organization worked so hard to remove re-enters through interpretation.
Configurable Clinical Intelligence closes that gap. It aligns the interpretive layer of the report — risk scoring, treatment pathways, educational language, and executive analytics — to an organization's own clinical philosophy, so every report reinforces enterprise standards. The paper walks through the four questions a well-designed enterprise report answers every time, the shift from isolated findings to a program-level view, and a real proof point from a practice that tracked the effect over the better part of a decade.
Every OraPath panel already carries this interpretive layer: pattern-based risk scores, prioritized clinical focus areas, and antibiotic considerations rather than a bare organism list.